Cancer screening company faces tough IPO test as market cools
Ammunition Life-tech has commercially launched five diagnostic tests for various types of cancer but could struggle to win over investors at an elevated valuation Key Takeaways: The company’s combined losses…
FAST NEWS: Burning Rock’s cancer test gets breakthrough designation
The latest: Cancer screening company Burning Rock Biotech Ltd. (BNR.US) announced Sunday that its OverC multi-cancer detection blood test (MCDBT) has been granted breakthrough device designation by the China National…
FAST NEWS: Genetron’s Losses Grow as Covid Restrictions Hurt Business
The latest: Cancer-screening device maker Genetron Holdings Ltd. (GTH.US) said on Thursday its revenue grew 9.6% year-on-year in the fourth quarter to 146.9 million yuan ($23 million). Its loss for…
RELATED ARTICLES
-
After winning global EV crown, BYD faces new challenge with profitability test
002594.SHE - Jacobio Pharma poised to turn a profit from precision cancer drugs
- Will yet another silicon carbide IPO test investor patience?
-
Lotus profit metrics improve, but road ahead still looks tough
LOT.US
- From friends to foes: Agile faces mounting troubles from former partner
